EDIT vs PLD · rev $32.3M vs P/E 27, rev $8.79B
Editas Medicine Inc (EDIT) versus Prologis Inc (PLD) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Prologis Inc (PLD) is a reit - industrial company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported PLD revenue for 2025-12-31 was $8.79B. Net income was $3.33B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
EDIT currently screens at market cap $375.2M. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
Not investment advice. Open the EDIT and PLD stock pages for the full models.
Not investment advice.